Hasson, Denise C. https://orcid.org/0000-0001-6172-4756
Demirkol, Demet
Barhight, Matthew F.
Selewski, David T.
Gorga, Stephen M.
Article History
Received: 20 May 2025
Accepted: 18 September 2025
First Online: 22 October 2025
Declarations
:
: Not applicable.
: Not applicable.
: DCH has a patent for the use of OLFM4 as a kidney injury biomarker. DTS is an Advisory board member of Intensive Care Medicine of Pediatric and Neonatal and a Gust Editor of the journal collection“Acute Kidney Injury.” Otherwise, the authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.